LPM6690176
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LPM6690176, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation [Phase 1, Phase 2]